Increased HVEM surface expression and high levels of sBTLA correlated with decreased overall survival (OS) and time to treatment (TTT) suggesting a role of BTLA/HVEM in the pathogenesis of CLL. Here, TNFRSF14 is linked to B-cell chronic lymphocytic leukemia.